Incidence and predictors for cardiovascular events in patients with psoriatic arthritis

被引:89
作者
Eder, Lihi [1 ]
Wu, Ying [2 ]
Chandran, Vinod [1 ]
Cook, Richard [2 ]
Gladman, Dafna D. [1 ]
机构
[1] Toronto Western Hosp, Ctr Prognosis Studies Rheumat Dis, Toronto, ON, Canada
[2] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON, Canada
基金
加拿大健康研究院;
关键词
Psoriatic Arthritis; Epidemiology; Atherosclerosis; Cardiovascular Disease; ATHEROSCLEROSIS RISK-FACTORS; POPULATION-BASED COHORT; RHEUMATOID-ARTHRITIS; SUBCLINICAL ATHEROSCLEROSIS; FRAMINGHAM RISK; DISEASE; INFLAMMATION; METAANALYSIS; PREVALENCE; INDIVIDUALS;
D O I
10.1136/annrheumdis-2015-207980
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To assess the incidence and risk factors of cardiovascular events in patients with psoriatic arthritis (PsA). Methods A cohort analysis was conducted involving patients recruited and followed over the period from 1978 to 2013 in a large PsA clinic. The participants were assessed at 6 to 12-month intervals according to a standard protocol. The collected information included demographics, lifestyle habits, medical history, medications use and PsA-related outcomes. The primary outcome was a composite major cardiovascular end point comprising myocardial infarction, ischaemic stroke, revascularisation or cardiovascular death. The association between the features of disease activity and the occurrence of cardiovascular events was assessed using Cox proportional hazard models. Results A total of 1091 patients with PsA were analysed. During the follow-up period, 104 cardiovascular events occurred. A considerable proportion of patients developed a cardiovascular event (19.8% of the patients by the age of 70 years and 30.1% of patient by the age of 80 years). No trend in the risk of developing cardiovascular events was observed over the decades from 1978 to 2013 (p=0.73). In multivariate analysis, the following variables were independent predictors of major cardiovascular events: hypertension (relative risk (RR) 1.81, p=0.015), diabetes (RR 2.72, p<0.001) and the number of dactylitic digits (RR 1.20, p<0.001). Sedimentation rate was a significant predictor only among women (RR 1.83, p=0.02). Conclusion A significant proportion of patients with PsA develop cardiovascular events during the course of their disease. Increased cardiovascular risk is associated with a combination of traditional cardiovascular risk factors and disease activity.
引用
收藏
页码:1680 / 1686
页数:7
相关论文
共 33 条
[1]   Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study [J].
Ahlehoff, O. ;
Gislason, G. H. ;
Charlot, M. ;
Jorgensen, C. H. ;
Lindhardsen, J. ;
Olesen, J. B. ;
Abildstrom, S. Z. ;
Skov, L. ;
Torp-Pedersen, C. ;
Hansen, P. R. .
JOURNAL OF INTERNAL MEDICINE, 2011, 270 (02) :147-157
[2]   The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients [J].
Arts, Elke E. A. ;
Fransen, Jaap ;
den Broeder, Alfons A. ;
Popa, Calin D. ;
van Riel, Piet L. C. M. .
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) :998-1003
[3]   Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study [J].
Corrales, Alfonso ;
Gonzalez-Juanatey, Carlos ;
Peiro, Maria E. ;
Blanco, Ricardo ;
Llorca, Javier ;
Gonzalez-Gay, Miguel A. .
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (04) :722-727
[4]   HLA-CLASS I GENES ARE ASSOCIATED WITH A HIGHER BURDEN OF ATHEROSCLEROSIS IN PATIENTS WITH PSORIATIC DISEASE [J].
Eder, L. ;
Abji, F. ;
Rosen, C. F. ;
Chandran, V. ;
Gladman, D. D. .
ATHEROSCLEROSIS, 2015, 241 (01) :E53-E53
[5]  
Eder L, 2015, ANN RHEUM DIS, V28, P546
[6]  
Eder L, 2008, J RHEUMATOL, V35, P877
[7]   The Framingham Risk Score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease [J].
Eder, Lihi ;
Chandran, Vinod ;
Gladman, Dafna D. .
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (11) :1990-1996
[8]   Predictors for clinical outcome in psoriatic arthritis - what have we learned from cohort studies? [J].
Eder, Lihi ;
Gladman, Dafna D. .
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2014, 10 (06) :763-770
[9]   Cardiovascular Risk Profile at the Onset of Psoriatic Arthritis: A Population-Based Cohort Study [J].
Ernste, F. C. ;
Sanchez-Menendez, M. ;
Wilton, K. M. ;
Crowson, C. S. ;
Matteson, E. L. ;
Kremers, H. Maradit .
ARTHRITIS CARE & RESEARCH, 2015, 67 (07) :1015-1021
[10]   Prevalence and treatment of psoriasis in the United Kingdom - A population-based study [J].
Gelfand, JM ;
Weinstein, R ;
Porter, SB ;
Neimann, AL ;
Berlin, JA ;
Margolis, D .
ARCHIVES OF DERMATOLOGY, 2005, 141 (12) :1537-1541